Clinical trial · Observational
Molecular and Cellular Analysis of Breast Cancer
NCT02243397CI-TRIAL-00098022completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast - Female | — | UNRESOLVED | — |
| Breast - Male | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- levels of GM-CSF in plasma
- timeFrame
- 10 years
- description
- We will be measuring levels of GM-CSF (Granulocyte-macrophayge colony stimulating factor) from the plasma of the patient before during and after the irradiation treatment to study if there is any increase in the GM-CSF production
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Minutes
Show eligibility criteria text
Inclusion Criteria: 1. Histologically proven diagnosis of breast cancer or a carcinoma of unknown primary consistent with the presentation of a primary breast malignancy. 2. 18 years of age or older. 3. Ability to understand and the willingness to sign a written informed consent do Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.